Source: PR Newswire

Press Release: Mirada : ConcertAI's TeraRecon Adds Mirada Medical to its AI Partner Program and Comprehensive Oncology Imaging Solutions

CAMBRIDGE, Mass., Aug. 2, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today the integration of MiradaXD, the multi-modality nuclear medicine imaging software by Mirada Medical, into its AI partner program. This expands its...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jon DeVries's photo - CEO of Mirada

CEO

Jon DeVries

CEO Approval Rating

82/100

Read more